N-bromoacetyltryptamine strongly and reversibly inhibits in vitro melatonin secretion from mammalian pinealocytes

Neuroendocrinology Letters

Volumn 26, Issue 5, 2005, Pages 581-592

  Lewczuk, Bogdan ^a   Zheng, Weiping ^b,c   Prusik, Magdalena ^a   Cole, Philip A ^b   Przybylska Gornowicz, Barbara ^a  

^a UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF AKRON   (United States)

Author keywords

Arylalkylamine N acetyltransferase; Inhibitor; Melatonin; N bromoacetyltryptamine; Pineal gland; Rat; Swine

Indexed keywords

ARALKYLAMINE ACETYLTRANSFERASE; ENZYME INHIBITOR; MELATONIN; N BROMOACETYLTRYPTAMINE; NORADRENALIN; UNCLASSIFIED DRUG;

ADRENERGIC STIMULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG STRUCTURE; EXPLANT; FEMALE; HORMONE BINDING; HORMONE DETERMINATION; HORMONE RELEASE; INHIBITION KINETICS; NONHUMAN; PINEALOCYTE; RADIOIMMUNOASSAY; RAT; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; SWINE;

EID: 29544449278     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Beaurain N, Mesangeau C, Chavatte P, Ferry G, Audinot V, Boutin JA, et al. Design, synthesis and in vitro evaluation of novel derivatives as serotonin N-acetyltransferase inhibitors. J Enzyme Inhib Med Chem 2002; 17:409-414.
2. Becker-Andre M, Wiesenberg I, Schaeren-Wiemers N, Andre E, Missbach M, Saurat JH, et al. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem 1994; 269:28531-28534.
3. Benitez-King G, Anton-Tay F. Calmodulin mediates melatonin cytoskeletal effects. Experientia, 1993; 49:635-641.
4. Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci 2002; 47:2336-2348.
5. Coon SL, Weller JL, Korf HW, Namboodiri MAA, Rollag M, Klein DC. cAMP regulation of arylalkylamine N-acetyltransferase (AANAT, EC 2.3.1.87) - A new cell line (1E7) provides evidence of intracellular AANAT activation. J Biol Chem 2001, 276:24097-24107.
6. Delagrange P, Atkinson J, Boutin JA, Casteilla L, Lesieur D, Misslin R, et al. Therapeutic perspectives for melatonin agonists and antagonists. J Neuroendocrinol 2003; 15:442-448.
7. Djeridane Y, Vivien-Roels B, Simonneaux V, Miguez JM, Pevet P. Evidence for melatonin synthesis in rodent Harderian gland: a dynamic in vitro study. J Pineal Res 1998; 25:54-64.
8. Drijfhout WJ, van der Linde AG, Kooi SE, Grol CJ, Westerink BH. Norepinephrine release in the rat pineal gland: the input from the biological clock measured by in vivo microdialysis. J Neurochem 1996; 66:748-755.
9. Dziegiel P, Murawska-Ciałowicz E, Jethon Z, Januszewska L Podhorska-Okołów M Surowiak P, et al. Melatonin stimulates the activity of protective antioxidative enzymes in myocardial cells of rats in the course of doxorubicin intoxication. J Pineal Res 2003; 35:183-187.
10. Ferry G, Boutin JA. High-capacity screening of arylalkylamine N-acetyltransferase inhibitors using a high-performance liquid chromatography system. J Biomol Screen 2000; 5:361-368
11. Ferry G, Mozo J, Ubeaud C, Berger S, Bertrand M, Try A, et al. Characterization and regulation of a CHO cell line stably expressing human serotonin N-acetyltransferase (EC 2.3.1.87). Cell Mol Life Sci 2002; 59:1395-1405
12. Ferry G, Ubeaud C, Mozo J, Pean Ch, Hennig P, Rodriguez M, et al. New substrate analogues of human serotonin N-acetyltransferase produce in situ specific and potent inhibitors. Eur J Biochem 2004; 271:418-428
13. von Gall C, Stehle JH, Weaver DR. Mammalian melatonin receptors: molecular biology and signal transduction. Cell Tissue Res 2002; 309:151-162.
14. Ganguly S, Gastel J, Weller JL, Schwartz C, Jaffe H, Namboodiri MAA, et al. Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-3-3-binding switch in melatonin synthesis. PNAS 2001; 98:8083-8088.
15. Gastel JA, Roseboom PH, Rinaldi PA, Weller JL, Klein DC. Melatonin production: proteasomal proteolysis in serotonin N-acetyltransferase regulation. Science 1998; 279:1358-1360.
16. Guerrero JM, Reiter RJ. Melatonin-immune system relationships. Curr Top Med Chem 2002; 2:167-179.
17. Hardeland R, Poeggeler B. Non-vertebrate melatonin. J Pineal Res 2003; 14:213-241.
18. Hickman AB, Namboodiri MA, Klein DC, Dyda F. The structural basis of ordered substrate binding by serotonin N-acetyltransferase: enzyme complex at 1.8 A resolution with a bisubstrate analog. Cell 1999; 97:361-369.
19. Hoffmann A, Farker K, Dittgen M, Hoffmann H. A melatonin preparation with a pulsatile liberation pattern: a new form of melatonin in replacement therapy. Biol Signals Recept 1999; 8:96-104 .
20. Karasek M, Pawlikowski M. Antiproliferative effects of melatonin and CGP 52608 . Biol Signals Recept 1999; 8:75-78.
21. Khalil EM, Cole PA. A potent inhibitor of the melatonin rhythm enzyme. J Am Chem Soc 1998; 120:6195-6196.
22. Khalil EM, De Angelis J, Ishii M, Cole PA. Mechanism-based inhibition of the melatonin rhythm enzyme: pharmacologic exploitation of active site functional plasticity. Proc Natl Acad Sci U S A 1999; 96:12418-12423.
23. Kim CM, Cole PA. Bisubstrate ketone analogues as serotonin N-acetyltransferase inhibitors. J Med Chem 2001; 44:2479-2485.
24. Krause DN, Geary GG, Doolen S, Duckles SP. Melatonin and cardiovascular system. In: Olcese J, editor. Melatonin after four decades. New York: Kluwer Academic/Plenum Publishers; 2000. p. 299-310.
25. Lewczuk B. Mechanisms of adrenergic regulation of melatonin secretion in the pig pineal gland - in vitro study. Dissertations and monographs, vol. 60 (in Polish), Olsztyn (Poland): UWM Press; 2002. p. 1-158
26. Lewczuk B, Przybylska-Gornowicz B. The effect of continuous darkness and illumination on the function and the morphology of the pineal gland in the domestic pig. I. The effect on plasma melatonin level. Neuroendocrinol Lett 2000; 21:283-291.
27. Li G, Li L, Yin D. A novel observation: Melatonin's interaction with malondiadehyde. Neuroendocrinol Lett 2005; 26:61-66
28. Maronde E, Schomerus C, Stehle JH, Korf HW. Control of CREB phosphorylation and its role for induction of melatonin syntheis in rat pinealocytes. Biol Cell 1997; 89: 505-511.
29. Maronde E, Pfeffer M, von Gall C, Dehghani F, Schomerus C, Wicht H, et al. Signal transduction in the rodent pineal organ. In: Olcese J, editor. Melatonin after four decades. New York: Kluwer Academic/Plenum Publishers; 2000. p. 109-132.
30. Mesangeau C , Yous S, Chavatte P, Ferry G, Audinot V, Boutin JA, et al. Design, synthesis and in vitro evaluation of novel benzo-β-thiophene derivatives as serotonin N-acetyltransferase (AANAT) inhibitors. J Enzyme Inhib Med Chem 2003; 18:119-125
31. Miguez JM, Simonneaux V, Pevet P. The role of the intracellular and extracellular serotonin in the regulation of melatonin production in rat pinealocytes. J Pineal Res 1997; 23:63-71.
32. Naïri-Skandrani L, Djeridane Y, Charbuy H, Touitou Y Isoproterenol-stimulated melatonin production by perifused rat pineal glands: Age- and time-related effects. Neuroendocrinol Lett 2004; 25:257-261
33. Namboodiri MA, Weller JL, Klein DC. Evidence of inactivation of pineal indoleamine N-acetyltransferase by protein thiol: disulfide exchange. J Biol Chem 1980; 255:6032-6035.
34. Obsil T, Ghirlando R, Klein DC, Ganguly S, Dyda F. Crystal structure of the 14-3-35 zeta : serotonin N-acetyltransferase complex: A role for scaffolding in enzyme regulation. Cell 2001; 105:257-267.
35. Paterson AM, Foldes A. Melatonin and farm animals: endogenous rhythms and exogenous applications. J Pineal Res 1994; 16:167-177.
36. Pawlikowski M, Winczyk K, Karasek M. Oncostatic action of melatonin: facts and question marks. Neuroendocrinol Lett 2002; 23 (Suppl 1):24-29.
37. Pevet P, Bothorel B, Slotten H, Saboureau M. The chronobiotic properties of melatonin. Cell Tissue Res 2002; 309:183-191.
38. Reiter RJ, Tan DX, Qi W, Manchester LC, Karbownik M, Calvo JR. Pharmacology and physiology of melatonin in the reduction of oxidative stress in vivo. Biol Signals Recept 2000; 9:160-171.
39. Reiter RJ, Tan DX, Burkhardt S, Manchester LC. Melatonin in plants. Nutr Rev 2001;59:286-290.
40. Sugden D, Klein DC. Inactivation of rat pineal hydroxyindole-O-methyltransferase by disulfide-containing compounds. J Biol Chem 1987; 262:6489-6493.
41. Tast A, Love RJ, Evans G, Telsfer S, Giles R, Nicholls P, et al. The pattern of melatonin secretion is rhythmic in the domestic pig and responds rapidly to changes in daylength. J Pineal Res 2001; 31:294-300.
42. Wetterberg L. Melatonin and clinical application. Reprod Nutr Dev 1999; 39:367-382
43. Witt-Enderby PA, Li PK. Melatonin receptors and ligands. Vitam Horm 2000; 58:321-354.
44. Yeleswaram K, McLaughlin LG, Knipe JO, Schabdach D. Pharmacokinetics and oral bioavailability of exogenous melatonin in preclinical animal models and clinical implications. J Pineal Res 1997; 22:45-51.
45. Zhao Z-Y, Touitou Y. Differences in isoproterenol-stimulated melatonin production by perifused rat pineal glands: time dependent effects and role of enantiomeric forms. Life Sci 1994; 54:497-502.
46. Zheng W, Scheibner KA, Ho AK, Cole PA. Mechanistic studies on the alkyltransferase activity of serotonin N-acetyltransferase. Chem Biol 2001; 8:379-389.